These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae. Watkins RR; Deresinski S Expert Rev Anti Infect Ther; 2017 Oct; 15(10):893-895. PubMed ID: 28914107 [No Abstract] [Full Text] [Related]
27. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation. Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354 [TBL] [Abstract][Full Text] [Related]
28. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance. Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255 [TBL] [Abstract][Full Text] [Related]
29. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand. Netikul T; Kiratisin P PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326 [TBL] [Abstract][Full Text] [Related]
30. Colistin-sparing approaches with newer antimicrobials to treat carbapenem-resistant organisms: Current evidence and future prospects. Veeraraghavan B; Pragasam AK; Bakthavatchalam YD; Anandan S; Swaminathan S; Sundaram B Indian J Med Microbiol; 2019; 37(1):72-90. PubMed ID: 31424014 [TBL] [Abstract][Full Text] [Related]
31. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A; Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106 [TBL] [Abstract][Full Text] [Related]
32. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. Logan LK; Weinstein RA J Infect Dis; 2017 Feb; 215(suppl_1):S28-S36. PubMed ID: 28375512 [TBL] [Abstract][Full Text] [Related]
33. A Snapshot of Co-Resistance to Carbapenems and Tigecycline in Clinical Isolates of Enterobacter cloacae. Huang LF; Lee CT; Su LH; Chang CL Microb Drug Resist; 2017 Jan; 23(1):1-7. PubMed ID: 27136494 [TBL] [Abstract][Full Text] [Related]
34. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings. Bou G; Vila J; Seral C; Castillo FJ Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049 [TBL] [Abstract][Full Text] [Related]
35. Circulation of Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268 [TBL] [Abstract][Full Text] [Related]
37. Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms. Tacão M; Correia A; Henriques IS Microb Drug Resist; 2015 Oct; 21(5):497-506. PubMed ID: 26430939 [TBL] [Abstract][Full Text] [Related]